19th IMS Annual Meeting

AUGUST 25-27, 2022 | LOS ANGELES, CALIFORNIA

Join me at the 19th International Myeloma Society Annual Meeting!

I'm excited to speak at the 19th IMS Annual Meeting in Los Angeles, California!

Cellular Therapy, Round Table discussion

About Mohamad Mohty: 

• Dr Mohty is the former president of the European Society for Blood and Marrow Transplantation (EBMT). He is also the founder and chairman of the International Academy for Clinical Hematology (IACH) and board member of the EBMT and the Intergroupe Francophone du Myelome (IFM). • His clinical and research interests are focused on different aspects of multiple myeloma therapy, including the impact of novel immunomodulatory agents, and immune therapies • Dr Mohty has published more than 850 peer-reviewed articles in the fields of stem cell transplantation, leukemia, and multiple myeloma in various hematology and immunology journals. Dr Mohty also serves as Editor-in-Chief of the journals Bone Marrow Transplantation and Clinical Hematology International.

About Our Meeting

The International Myeloma Society Annual Meeting is the defining meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects, including: 

  • Scientific Programs
  • Keynote Addresses
  • Poster Presentations
  • Oral Presentations (Basic Biology, Preclinical Trials and Clinical Studies)

Testimonials

“I’ve already come away with so many great ideas from the interactions and discussions here in Vienna. You just can’t get that any other way. It's what’s been missing for the past 2 years!”

 

STEVEN P. TREON, MD, PhD, FACP, FRCP

Dana Farber Cancer Institute

Boston, MA

“The 18th International Myeloma Workshop in Vienna. A milestone. Immunotherapies definitely revolutionize the treatment and challenge autologous transplantation. A very special congress I will always remember.”

 

LAURENT GARDERET, MD, PhD 

Sorbonne Université, APHP

Paris, France

Join Us in Los Angeles

FacebookTwitter